Persistent pulmonary hypertension of the newborn

Area of Science:

• Neonatal Medicine
• Pediatric Cardiology
• Pulmonary Hypertension

Background:

• Persistent pulmonary hypertension of the newborn (PPHN) involves elevated pulmonary vascular resistance, leading to right-to-left shunting and hypoxemia.
• PPHN can be secondary to lung disease or hypoplasia, or idiopathic.
• Diagnosis relies on clinical signs of hypoxemia and differential cyanosis, confirmed by echocardiography.

Purpose of the Study:

• To review the diagnostic criteria and management strategies for PPHN.
• To highlight the impact of medical advancements on treatment outcomes and the persistent challenges of long-term neurodevelopmental disabilities.

Main Methods:

• Clinical diagnosis based on labile hypoxemia and differential cyanosis.
• Echocardiographic confirmation of shunting, septal deviation, tricuspid regurgitation, and absence of structural heart disease.
• Review of management strategies including oxygenation, acid-base balance, blood pressure, sedation, and vasodilator therapy.

Main Results:

• Echocardiography confirms PPHN by demonstrating specific shunt patterns and cardiac structural findings.
• Medical management has reduced the reliance on extracorporeal membrane oxygenation (ECMO) as a rescue therapy.
• Improved survival rates are noted, but long-term neurodevelopmental disabilities remain a concern.

Conclusions:

• Effective management of PPHN involves optimizing oxygenation, acid-base status, hemodynamics, and utilizing vasodilator therapy.
• While ECMO use has decreased, long-term neurodevelopmental outcomes like deafness and learning disabilities require ongoing attention in severe PPHN cases.